XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents $ 7,786 $ 6,515
Short-term investments 4,181 7,826
Accounts receivable (net of allowance for doubtful accounts of $200 in 2017 and $195 in 2016) 7,439 7,018
Inventories (excludes inventories of $1,076 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5) 5,407 4,866
Other current assets 3,354 4,389
Total current assets 28,167 30,614
Investments 12,138 11,416
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,375 in 2017 and $15,749 in 2016 12,094 12,026
Goodwill 18,358 18,162
Other Intangibles, Net 16,119 17,305
Other Assets 5,928 5,854
Total Assets 92,804 95,377
Current Liabilities    
Loans payable and current portion of long-term debt 3,181 568
Trade accounts payable 2,934 2,807
Accrued and other current liabilities 9,363 10,274
Income taxes payable 1,979 2,239
Dividends payable 1,301 1,316
Total current liabilities 18,758 17,204
Long-Term Debt 21,706 24,274
Deferred Income Taxes 4,560 5,077
Other Noncurrent Liabilities 8,068 8,514
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016 1,788 1,788
Other paid-in capital 39,776 39,939
Retained earnings 45,046 44,133
Accumulated other comprehensive loss (5,094) (5,226)
Stockholders' equity before deduction for treasury stock 81,516 80,634
Less treasury stock, at cost: 849,974,743 shares in 2017 and 828,372,200 shares in 2016 42,053 40,546
Total Merck & Co., Inc. stockholders’ equity 39,463 40,088
Noncontrolling Interests 249 220
Total equity 39,712 40,308
Liabilities and Equity $ 92,804 $ 95,377